Related Experiment Video
Updated: Aug 6, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Large Vessel Occlusion Stroke due to Intracranial Atherosclerotic Disease: Identification, Medical and Interventional
Adam de Havenon1, Osama O Zaidat2, Sepideh Amin-Hanjani3
1Neurology, Yale University, New Haven, CT (A.d.H., A.B., M.A.).
Insights
Intracranial atherosclerotic disease causing large vessel occlusion stroke (ICAD-LVO) requires specific management. Early identification and treatment planning are crucial for successful endovascular thrombectomy outcomes in these patients.
Area of Science:
- Neurology
- Vascular Neurology
- Interventional Neurology
Background:
- Large vessel occlusion stroke (LVO) is frequently caused by intracranial atherosclerotic disease (ICAD-LVO), affecting 10-30% of cases.
- Patients with ICAD-LVO benefit from endovascular thrombectomy, but face high rates of reocclusion post-procedure.
- Unique management considerations exist for ICAD-LVO before, during, and after endovascular thrombectomy.
Purpose of the Study:
- To propose a comprehensive, multistep approach for managing ICAD-LVO.
- To outline strategies for identification, pretreatment, and post-treatment care in ICAD-LVO patients undergoing endovascular thrombectomy.
- To synthesize current knowledge on ICAD-LVO management, given the lack of large randomized controlled trials.
Main Methods:
- Review of observational studies focusing on ICAD-LVO.
- Synthesis of data on patient factors influencing ICAD-LVO prevalence.
- Analysis of treatment considerations and outcomes for ICAD-LVO.
Main Results:
- ICAD-LVO is a significant cause of LVO, influenced by vascular risk factors, race, ethnicity, and age.
- Endovascular thrombectomy offers functional benefits comparable to other LVO etiologies.
- High rates of reocclusion (up to 50%) are observed in ICAD-LVO patients post-thrombectomy.
Conclusions:
- Early identification and tailored treatment planning are essential for optimizing outcomes in ICAD-LVO.
- A structured approach encompassing identification, pretreatment, thrombectomy, and medical management is proposed.
- Further research, potentially including dedicated trials, is needed to refine ICAD-LVO treatment strategies.
Abstract:
Large vessel occlusion stroke due to underlying intracranial atherosclerotic disease (ICAD-LVO) is prevalent in 10 to 30% of LVOs depending on patient factors such as vascular risk factors, race and ethnicity, and age. Patients with ICAD-LVO derive similar functional outcome benefit from endovascular thrombectomy as other mechanisms of LVO, but up to half of ICAD-LVO patients reocclude after revascularization. Therefore, early identification and treatment planning for ICAD-LVO are important given the unique considerations before, during, and after endovascular thrombectomy. In this review of ICAD-LVO, we propose a multistep approach to ICAD-LVO identification, pretreatment and endovascular thrombectomy considerations, adjunctive medications, and medical management. There have been no large-scale randomized controlled trials dedicated to studying ICAD-LVO, therefore this review focuses on observational studies.
Related Concept Videos
Aneurysm III: Interprofessional Care
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis IV: Nursing Management

